newsfilter
← Latest News
PR Newswire·

BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and ot